1479-1641

Diabetes and Vascular Disease Research

SAGE Publications

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 738 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact738 DOIs
2

Add abstracts to 125 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact125 DOIs
3

Deposit reference lists for 31 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact31 DOIs

DOIs for this ISSN

Showing the top 5 of 1039 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular… (10.1177/1479164114525548)
Abstract ORCID
113.00 181
2 Metformin: a multitasking medication (10.3132/dvdr.2008.026)
Abstract References ORCID
92.28 16
3 Hsa-circRNA11783-2 in peripheral blood is correlated with co… (10.1177/1479164117722714)
Abstract ORCID
92.25 69
4 High glucose–induced endothelial progenitor cell dysfunction (10.1177/1479164117719058)
Abstract ORCID
90.98 65
5 HOMA-beta in the UKPDS and ADOPT. Is the natural history of… (10.1177/1479164109336038)
Abstract ORCID
83.60 46
6 Obstructive sleep apnoea in diabetes: Does it matter? (10.1177/1479164117714397)
Abstract ORCID
82.66 44
7 Insulin replacement limits progression of diabetic cardiomyo… (10.1177/1479164117710390)
Abstract ORCID
81.16 41
8 Four decades of uncertainty: landmark trials in glycaemic co… (10.3132/dvdr.2008.036)
Abstract ORCID
77.20 34
9 C-peptide: A predictor of cardiovascular mortality in subjec… (10.1177/1479164117710446)
Abstract ORCID
75.93 32
10 Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory… (10.1177/1479164117715855)
Abstract ORCID
75.26 31
11 Importance of mitochondrial calcium uniporter in high glucos… (10.1177/1479164117723270)
Abstract ORCID
71.57 26
12 Evaluating thiamine deficiency in patients with diabetes (10.3132/dvdr.2006.014)
Abstract ORCID
70.75 25
13 The 10-year post-trial follow-up of the United Kingdom Prosp… (10.3132/dvdr.2009.012)
Abstract ORCID
70.75 25
14 Correlation between radial artery tonometry- and fingertip t… (10.3132/dvdr.2007.011)
Abstract ORCID
69.01 23
15 CXC chemokine ligand 16 is increased in gestational diabetes… (10.1177/1479164117728011)
Abstract ORCID
68.09 22
16 Apoptosis, vascular leakage and increased risk of severe den… (10.3132/dvdr.2008.034)
Abstract ORCID
68.09 22
17 2013 ESC/EASD guidelines on the management of diabetes and c… (10.1177/1479164113512859)
Abstract ORCID
67.12 21
18 Decreased glucagon-like peptide 1 receptor expression in end… (10.1177/1479164117725898)
Abstract ORCID
67.12 21
19 The tumour suppressor CDKN2A/p16 <sup>IN… (10.1177/1479164117728012)
Abstract ORCID
63.94 18
20 Probing SGLT2 as a therapeutic target for diabetes: Basic ph… (10.1177/1479164114561992)
ORCID
63.57 348
21 SGLT-2 inhibitors and cardiovascular risk: Proposed pathways… (10.1177/1479164114559852)
ORCID
63.00 330
22 Insulin resistance and insulin hypersecretion in the metabol… (10.1177/1479164119827611)
ORCID
59.90 248
23 Cross-sectional evaluation of the Finnish Diabetes Risk Scor… (10.3132/dvdr.2005.011)
ORCID
59.90 248
24 Metformin therapy and clinical uses (10.3132/dvdr.2008.027)
ORCID
59.60 241
25 Homocysteine and cardiovascular disease: a review of the evi… (10.3132/dvdr.2007.033)
ORCID
58.41 216
26 The clock stopped, never to go again… (10.3132/dvdr.2008.0012)
Abstract References ORCID
58.36 5
27 The Residual Risk Reduction Initiative: a call to action to… (10.3132/dvdr.2008.046)
ORCID
58.31 214
28 Metabolic syndrome, or What you will: definitions and epidem… (10.3132/dvdr.2007.003)
ORCID
58.16 211
29 The endothelium and vascular inflammation in diabetes (10.3132/dvdr.2007.025)
ORCID
57.79 204
30 The impact of smoking on the development of diabetes and its… (10.1177/1479164117701876)
ORCID
57.36 196
31 High burden of coronary atherosclerosis in patients with a n… (10.1177/1479164117728014)
Abstract ORCID
57.31 13
32 Design and baseline characteristics of the CARdiovascular Ou… (10.1177/1479164115570301)
ORCID
56.91 188
33 Review article: Coagulation and fibrinolysis in diabetes (10.1177/1479164110383723)
ORCID
56.85 187
34 Cellular and molecular mechanisms of endothelial dysfunction… (10.1177/1479164113500680)
ORCID
56.80 186
35 A GLP-1 receptor agonist liraglutide inhibits endothelial ce… (10.1177/1479164111404257)
ORCID
56.68 184
36 Review article: Platelet abnormalities in diabetes mellitus (10.1177/1479164110383994)
ORCID
56.20 176
37 Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emergin… (10.3132/dvdr.2006.024)
ORCID
55.95 172
38 Pancreatic-β-cell survival and proliferation are promoted by… (10.1177/1479164117713947)
Abstract ORCID
55.70 12
39 Baseline characteristics of the randomised cohort from the L… (10.3132/dvdr.2006.031)
ORCID
54.33 148
40 New perspectives on the management of diabetic peripheral ne… (10.3132/dvdr.2006.013)
ORCID
54.03 144
41 Diabetes mellitus increases the risk of ruptured abdominal a… (10.1177/1479164117710391)
Abstract ORCID
53.96 11
42 Effects of aliskiren on mortality, cardiovascular outcomes a… (10.1177/1479164117715854)
Abstract ORCID
53.96 11
43 Empagliflozin reduces body weight and indices of adipose dis… (10.1177/1479164115616901)
ORCID
53.73 140
44 Diabetes mellitus is associated with adverse prognosis in ch… (10.1177/1479164112471064)
ORCID
53.58 138
45 Interrelationship of canonical and non-canonical Wnt signall… (10.1177/1479164117738442)
ORCID
53.50 137
46 The GLP-1 receptor agonist liraglutide inhibits progression… (10.1177/1479164113481817)
ORCID
53.42 136
47 Gaps and barriers in the control of blood glucose in people… (10.1177/1479164116679775)
ORCID
53.10 132
48 The prevalence of left ventricular diastolic dysfunction and… (10.1177/1479164118787415)
ORCID
52.93 130
49 Obesity, adipocytes and squirrels (10.3132/dvdr.2004.014)
Abstract References ORCID
52.42 4
50 Hyperglycaemia and its therapy during acute coronary syndrom… (10.3132/dvdr.2008.037)
Abstract References ORCID
52.42 4